Brunetto A L, Pearson A D, Gibson R, Bateman D N, Rashid M U, Laker M F
Department of Child Health, University of Newcastle upon Tyne, Medical School, UK.
Eur J Clin Invest. 1990 Jun;20(3):279-84. doi: 10.1111/j.1365-2362.1990.tb01856.x.
The present study examined the hypothesis that altered motility of the gastrointestinal tract affects absorption of probe markers of intestinal permeability. Seven healthy subjects, aged 32-44 years, received saline, 600 micrograms atropine or 10 mg metoclopramide in randomized order at weekly intervals. After 10 min they ingested a test solution containing 5 g lactulose, 5 g mannitol and 2 g 3-O-methyl glucose in 100 ml tap water. The molarity of the solution was 542 mmol l-1 and the dose administered was 80 ml m-2 body surface area. Gastric emptying was measured by ultrasound, mouth-to-caecum transit time by breath hydrogen analysis and sugar concentrations by gas-liquid chromatography. Gastric emptying half-times (min) were [mean (95% confidence intervals)] 14.9 (11:4-18.5) after saline, 22 (18.7-25.2) after atropine and 10.3 (7.0-12.6) after metoclopramide (P less than 0.002). Transit times (min) were 68.9 (52-85.2) after saline, 143 (126-159) after atropine and 38 (21.2-54.5) after metoclopramide; P less than 0.0001. Analysis of plasma levels of mannitol and 3-O-methyl glucose showed a significant within-subject effect of drug with time (P less than 0.03). Urinary excretion of mannitol in the first 5 h after ingestion of the test solution was 1256 (974-1620) mg after saline, 1560 (1210-2013) mg after atropine and 955 (740-1232) mg after metoclopramide (P less than 0.03). There were no significant differences in lactulose and 3-O-methyl glucose urinary excretion between drug treatments.(ABSTRACT TRUNCATED AT 250 WORDS)
胃肠道运动的改变会影响肠通透性探针标志物的吸收。7名年龄在32 - 44岁的健康受试者,以随机顺序每周接受一次生理盐水、600微克阿托品或10毫克甲氧氯普胺。10分钟后,他们摄入一种测试溶液,该溶液含有5克乳果糖、5克甘露醇和2克3 - O - 甲基葡萄糖,溶于100毫升自来水中。溶液的摩尔浓度为542毫摩尔/升,给药剂量为80毫升/平方米体表面积。通过超声测量胃排空,通过呼气氢分析测量口至盲肠转运时间,通过气液色谱法测量糖浓度。胃排空半衰期(分钟)分别为:生理盐水后为14.9(11.4 - 18.5)[均值(95%置信区间)],阿托品后为22(18.7 - 25.2),甲氧氯普胺后为10.3(7.0 - 12.6)(P < 0.002)。转运时间(分钟)分别为:生理盐水后为68.9(52 - 85.2),阿托品后为143(126 - 159),甲氧氯普胺后为38(21.2 - 54.5);P < 0.0001。血浆中甘露醇和3 - O - 甲基葡萄糖水平的分析显示,药物对受试者有显著的随时间变化的效应(P < 0.03)。摄入测试溶液后前5小时内,甘露醇的尿排泄量分别为:生理盐水后为1256(974 - 1620)毫克,阿托品后为1560(1210 - 2013)毫克,甲氧氯普胺后为955(740 - 1232)毫克(P < 0.03)。药物治疗之间乳果糖和3 - O - 甲基葡萄糖的尿排泄量无显著差异。(摘要截短至250字)